Why the study?
What are the circulatory and respiratory effects of different doses of intravenous Prostaglandin E1 in healthy male subjects?
What are the circulatory and respiratory effects of different doses of intravenous Prostaglandin E1 in healthy male subjects?
Answers are grounded in this paper and cite their sources.
Intravenous Prostaglandin E1 induces dose-dependent hyperkinetic circulatory changes and respiratory effects, including alveolar hyperventilation at higher doses, in healthy men.
Prostaglandin E 1 (PGE 1 ) was infused i.v. into 8 healthy male subjects in doses from 0.032 to 0.58 μg/kg/min. With doses from 0.058 to 0.10 μg/kg/min a hyperkinetic circulation was induced, characterized by an increase in heart rate and stroke volume, decrease in peripheral resistance, and a decrease in AVO 2 difference and simultaneously a less pronounced increase in O 2 uptake. At the higher dose levels there was a further increase in heart rate and decrease in brachial artery pressure. The stroke volume decreased but the cardiac output remained above resting levels. The high doses also produced an alveolar hyperventilation, a further increase in O 2 consumption and in three cases a respiratory alkalosis.
No takes yet. Share an insight, caveat, or question.
Carlson et al. (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: